
### [MONDO:0004868](http://purl.obolibrary.org/obo/MONDO_0004868)
**Label:** biliary tract disease

**Subclasses:** [MONDO:0018646](http://purl.obolibrary.org/obo/MONDO_0018646) (sclerosing cholangitis (disease)), [MONDO:0015762](http://purl.obolibrary.org/obo/MONDO_0015762) (progressive familial intrahepatic cholestasis), [MONDO:0015116](http://purl.obolibrary.org/obo/MONDO_0015116) (rare biliary tract disease), [MONDO:0013433](http://purl.obolibrary.org/obo/MONDO_0013433) (primary sclerosing cholangitis), [MONDO:0019008](http://purl.obolibrary.org/obo/MONDO_0019008) (benign recurrent intrahepatic cholestasis), [MONDO:0008265](http://purl.obolibrary.org/obo/MONDO_0008265) (isolated polycystic liver disease), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0019072](http://purl.obolibrary.org/obo/MONDO_0019072) (intrahepatic cholestasis), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), [MONDO:0007318](http://purl.obolibrary.org/obo/MONDO_0007318) (Alagille syndrome), [MONDO:0005388](http://purl.obolibrary.org/obo/MONDO_0005388) (primary biliary cholangitis), [MONDO:0015509](http://purl.obolibrary.org/obo/MONDO_0015509) (genetic biliary tract disease), [MONDO:0011559](http://purl.obolibrary.org/obo/MONDO_0011559) (benign recurrent intrahepatic cholestasis type 2), [MONDO:0009061](http://purl.obolibrary.org/obo/MONDO_0009061) (cystic fibrosis), 

**Corr. equiv. classes:** [Orphanet:447771](http://www.orpha.net/ORDO/Orphanet_447771), [Orphanet:156607](http://www.orpha.net/ORDO/Orphanet_156607), [Orphanet:586](http://www.orpha.net/ORDO/Orphanet_586), [OMIM:219700](http://purl.obolibrary.org/obo/OMIM_219700), [Orphanet:172](http://www.orpha.net/ORDO/Orphanet_172), [Orphanet:300557](http://www.orpha.net/ORDO/Orphanet_300557), [Orphanet:52](http://www.orpha.net/ORDO/Orphanet_52), [Orphanet:186](http://www.orpha.net/ORDO/Orphanet_186), [OMIM:605479](http://purl.obolibrary.org/obo/OMIM_605479), [Orphanet:171](http://www.orpha.net/ORDO/Orphanet_171), [Orphanet:69665](http://www.orpha.net/ORDO/Orphanet_69665), [Orphanet:101941](http://www.orpha.net/ORDO/Orphanet_101941), [Orphanet:65682](http://www.orpha.net/ORDO/Orphanet_65682), [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:2924](http://www.orpha.net/ORDO/Orphanet_2924), [OMIM:174050](http://purl.obolibrary.org/obo/OMIM_174050), [Orphanet:99961](http://www.orpha.net/ORDO/Orphanet_99961), [OMIM:613806](http://purl.obolibrary.org/obo/OMIM_613806), 

**Class expressions from DL-Learner:**

- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) 59.53%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology))) 57.49%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity))) 57.49%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology))) 55.40%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay))) 55.40%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion))) 55.40%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail))) 55.40%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast))) 55.40%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0100606](http://purl.obolibrary.org/obo/HP_0100606) (Neoplasm of the respiratory system))) 53.59%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0100526](http://purl.obolibrary.org/obo/HP_0100526) (Neoplasm of the lung))) 53.59%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0031137](http://purl.obolibrary.org/obo/HP_0031137) (Storage in hepatocytes))) 53.59%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier))) 53.59%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology))) 53.59%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 53.59%
- [HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology) and (not ([HP:0010787](http://purl.obolibrary.org/obo/HP_0010787) (Genital neoplasm))) 53.59%


